Nebido 1000 mg 4 ml x 1 Ampolla Solución Inyectable Cenabast
If your age is advanced, the risk of developing prostate enlargement during the use of androgens such as NEBIDO® may be higher. Although there is no clear evidence that androgens constitute prostate cancer, they may increase the growth of existing prostate cancer. Due to the sterile nature of the medication and the specific injection technique required, Naposim 10 mg Vermodje NEBIDO should only be administered by a trained healthcare professional. This ensures proper placement of the injection, minimizing the risk of infection or nerve damage. Additionally, a healthcare provider can monitor testosterone levels through blood tests and adjust the dosage or frequency of injections as needed.
- Your doctor will regularly examine your prostate and breast, especially if you are elderly.
- If your testosterone levels are high, your doctor may decide to give you injections less often.
- Following intravenous infusion of testosterone to elderly men, the elimination half-life of testosterone was approximately one hour and an apparent volume of distribution of about 1.0 l/kg was determined.
If you miss a scheduled NEBIDO injection, contact your doctor for guidance. They will likely advise on rescheduling the injection or adjusting the dosage plan depending on how far past your due date you are. It’s important not to attempt to double the dose to compensate for a missed injection. The most common side effects are acne and pain where the injection isgiven.
The most appropriate MedDRA term to describe a certain adverse reaction is listed. Synonyms or related conditions are not listed, but should be taken into account as well. Nebido is not indicated for use in women and must not be used in pregnant or breast-feeding women, see section 4.3.
what you need to know before you are given nebido
In case of high serum levels an extension of the injection interval may be considered. As with all oily solutions, Nebido must be injected strictly intramuscularly and very slowly (over two minutes). Pulmonary microembolism of oily solutions can in rare cases lead to signs and symptoms such as cough, dyspnoea, malaise, hyperhidrosis, chest pain, dizziness, paraesthesia, or syncope. These reactions may occur during or immediately after the injection and are reversible. The patient should therefore be observed during and immediately after each injection in order to allow for early recognition of possible signs and symptoms of pulmonary oily microembolism. Treatment is usually supportive, e.g. by administration of supplemental oxygen.
There are no studies undertaken to demonstrate the efficacy and safety of this medicinal product in patients with renal or hepatic impairment. Therefore, testosterone replacement therapy should be used with caution in these patients. Male hormones may increase the development of prostate cancer and the growth of benign prostate gland (benign prostatic hypertrophy). Before injecting NEBIDO®, your doctor will examine you to check for prostate cancer.
• NEBIDO® contains 1000 mg of testosterone undecanoate in 4 ml of solution. Adverse events reported during use of a given product may occur in patients who are treated with any Nebido 1000mg/4 ml (Nebido 1000mg/4 ml (transdermal)) product. Androgens may decrease levels of thyroxin-binding globulin, resulting in decreased total T.
Ako uchovávať Nebido
You should not abuse this medicine alone or with other anabolic androgenic steroids because it carries serious health risks. ► blood-thinning tablets (coumarin derived oral anticoagulants) since this can increase the risk of bleeding. Please be sure to inform your doctor if you suffer from a disturbance of blood clotting, because this is important for your doctor to know before deciding to inject Nebido. Nebido may also affect the results of some laboratory tests (e.g. thyroid gland).
Special care will be taken to avoid injection into a blood vessel (see “Administration”). The injection interval should always be within the recommended range of 10 to 14 weeks. The solution for intramuscular injection is to be visually inspected prior to use and only clear solutions free from particles should be used. NEBIDO is a formulation of testosterone undecanoate, a long-acting ester of testosterone. This ester modification allows for a slow and steady release of testosterone into the bloodstream over an extended period, typically weeks after injection.
The major active metabolites of testosterone are oestradiol and dihydrotestosterone. Only the free fraction of testosterone is considered as biologically active. Following intravenous infusion of testosterone to elderly men, the elimination half-life of testosterone was approximately one hour and an apparent volume of distribution of about 1.0 l/kg was determined.
If prescription or Please inform your doctor or pharmacist if you are currently using any prescription medication or have recently used it. Contained in NEBIDO® NEBIDO® may cause serious allergic reactions due to the castor oil contained in it. A contact sensitization rate of 0.5% for Nebido 1000mg/4 ml (Nebido 1000mg/4 ml (transdermal)) TTS was observed in a 6-week study of 233 normal male volunteers.
